XenoPort Stock Price, News & Analysis (NASDAQ:XNPT)

Previous Close$7.02
Today's RangeN/A
52-Week RangeN/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E Ratio-5.84
Dividend YieldN/A
BetaN/A

About XenoPort (NASDAQ:XNPT)

XenoPort logoXenoPort, Inc. is a biopharmaceutical company. The Company is focused on commercializing HORIZANT (gabapentin enacarbil) Extended-Release Tablets in the United States. The Company's segment is the development and commercialization of product candidates for the treatment of neurological and other disorders. Its development-stage product candidates include XP23829, XP21279 and arbaclofen placarbil. HORIZANT has been approved by the United States Food and Drug Administration for the treatment of moderate-to-severe primary restless legs syndrome in adults and for the management of postherpetic neuralgia in adults. XP23829 is a fumaric acid ester compound and a prodrug of metabolite monomethyl fumarate being developed for the treatment for patients with moderate-to-severe chronic plaque-type psoriasis and/or patients with relapsing forms of multiple sclerosis. XP21279 is a Transported Prodrug of levodopa being developed for the treatment for patients with idiopathic Parkinson's disease.

Receive XNPT News and Ratings via Email

Sign-up to receive the latest news and ratings for XNPT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceuticals
Sub-IndustryPharmaceuticals
SectorHealthcare
SymbolNASDAQ:XNPT
CUSIP98411C10
Phone+1-408-6167200

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E Ratio-5.84297520661157
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPS($1.21)
Net IncomeN/A
Net Margins-103.12%
Return on Equity-414.36%
Return on Assets-37.19%

Miscellaneous

EmployeesN/A
Outstanding SharesN/A

XenoPort (NASDAQ:XNPT) Frequently Asked Questions

What is XenoPort's stock symbol?

XenoPort trades on the NASDAQ under the ticker symbol "XNPT."

How were XenoPort's earnings last quarter?

XenoPort, Inc. (NASDAQ:XNPT) issued its quarterly earnings data on Thursday, May, 5th. The biopharmaceutical company reported ($0.23) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.21) by $0.02. The biopharmaceutical company had revenue of $14.12 million for the quarter, compared to the consensus estimate of $14.24 million. XenoPort had a negative net margin of 103.12% and a negative return on equity of 414.36%. The firm's revenue for the quarter was up 99.7% on a year-over-year basis. During the same quarter last year, the company earned ($0.33) EPS. View XenoPort's Earnings History.

Who are some of XenoPort's key competitors?

How do I buy XenoPort stock?

Shares of XenoPort can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How can I contact XenoPort?

XenoPort's mailing address is 2000 Seaport Blvd Ste 300, REDWOOD CITY, CA 94063-5584, United States. The biopharmaceutical company can be reached via phone at +1-408-6167200.


MarketBeat Community Rating for XenoPort (XNPT)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  123 (Vote Outperform)
Underperform Votes:  104 (Vote Underperform)
Total Votes:  227
MarketBeat's community ratings are surveys of what our community members think about XenoPort and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

XenoPort (NASDAQ:XNPT) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: N/AN/AN/AN/A
Consensus Rating Score: N/AN/AN/AN/A
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

XenoPort (NASDAQ:XNPT) Consensus Price Target History

Price Target History for XenoPort (NASDAQ:XNPT)

XenoPort (NASDAQ:XNPT) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/24/2016Jefferies GroupReiterated RatingBuyN/AView Rating Details
5/6/2016CowenReiterated RatingHoldN/AView Rating Details
(Data available from 2/21/2016 forward)

Earnings

XenoPort (NASDAQ:XNPT) Earnings History and Estimates Chart

Earnings by Quarter for XenoPort (NASDAQ:XNPT)

XenoPort (NASDAQ XNPT) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/5/2016Q116($0.21)($0.23)$14.24 million$14.12 millionViewN/AView Earnings Details
2/25/2016Q415($0.31)($0.21)$13.74 million$14.07 millionViewListenView Earnings Details
11/4/2015Q315($0.38)($0.38)$11.77 million$11.40 millionViewN/AView Earnings Details
8/5/2015Q215($0.32)($0.39)$9.77 million$8.60 millionViewN/AView Earnings Details
5/6/2015Q115($0.29)($0.33)$8.50 million$7.10 millionViewN/AView Earnings Details
2/19/2015Q414($0.34)($0.28)$7.10 million$7.10 millionViewN/AView Earnings Details
11/4/2014Q314($0.36)$0.13$6.30 million$31.10 millionViewN/AView Earnings Details
8/6/2014Q214($0.33)($0.31)$4.38 million$5.30 millionViewN/AView Earnings Details
5/8/2014Q114($0.32)($0.36)$3.86 million$3.40 millionViewListenView Earnings Details
2/20/2014Q413($0.45)($0.40)$3.35 million$2.90 millionViewListenView Earnings Details
11/4/2013Q313($0.51)($0.39)$3.03 million$2.52 millionViewN/AView Earnings Details
8/6/2013Q2 2013($0.53)($0.51)$1.74 million$2.10 millionViewN/AView Earnings Details
4/24/2013Q1 2013($0.43)($0.50)$1.20 million$4.59 millionViewN/AView Earnings Details
3/11/2013Q4 2012($0.42)$0.07$1.02 million$0.49 millionViewN/AView Earnings Details
10/24/2012Q312($0.43)($0.41)$2.26 million$0.40 millionViewN/AView Earnings Details
8/7/2012($0.39)($0.22)ViewN/AView Earnings Details
5/2/2012($0.22)($0.26)ViewN/AView Earnings Details
2/14/2012($0.39)($0.48)ViewN/AView Earnings Details
11/2/2011($0.44)($0.55)ViewN/AView Earnings Details
8/3/2011($0.23)$0.55ViewN/AView Earnings Details
5/5/2011($0.49)($0.49)ViewN/AView Earnings Details
2/16/2011($0.62)($0.47)ViewN/AView Earnings Details
11/8/2010Q3 2010($0.65)($0.65)ViewN/AView Earnings Details
8/5/2010Q2 2010($0.61)($0.64)ViewN/AView Earnings Details
5/6/2010Q1 2010($0.72)($0.75)ViewN/AView Earnings Details
2/22/2010Q4 2009($0.80)($0.60)ViewN/AView Earnings Details
11/3/2009Q3 2009($0.76)($0.81)ViewN/AView Earnings Details
8/5/2009Q2 2009($0.85)($0.76)ViewN/AView Earnings Details
5/5/2009Q1 2009($0.31)($0.10)ViewN/AView Earnings Details
2/12/2009Q4 2008($0.77)($0.74)ViewN/AView Earnings Details
11/5/2008Q3 2008($0.35)($0.96)ViewN/AView Earnings Details
8/6/2008Q2 2008($0.09)($0.49)ViewN/AView Earnings Details
5/7/2008Q1 2008($0.05)($0.29)ViewN/AView Earnings Details
2/14/2008Q4 2007($0.06)$0.09ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

XenoPort (NASDAQ:XNPT) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for XenoPort (NASDAQ:XNPT)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

XenoPort (NASDAQ XNPT) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for XenoPort (NASDAQ:XNPT)
Insider Trades by Quarter for XenoPort (NASDAQ:XNPT)

XenoPort (NASDAQ XNPT) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/19/2016James E FlynnInsiderBuy20,973$3.99$83,682.27View SEC Filing  
2/12/2016James E FlynnInsiderBuy4,883,761$3.87$18,900,155.07View SEC Filing  
1/20/2016James E FlynnInsiderBuy346,417$4.09$1,416,845.53View SEC Filing  
9/1/2015Ronald W BarrettCEOSell12,500$7.00$87,500.00191,703View SEC Filing  
7/15/2015Ronald W BarrettCEOSell12,500$7.20$90,000.00View SEC Filing  
7/13/2015Ronald W BarrettCEOSell12,500$7.00$87,500.00View SEC Filing  
5/11/2015Wendall WierengaDirectorBuy5,000$5.63$28,150.00View SEC Filing  
12/8/2014Gregory T BatesSVPSell14,166$8.35$118,286.10View SEC Filing  
12/8/2014Ronald W BarrettCEOSell7,015$8.36$58,645.40View SEC Filing  
12/5/2014Gianna M BoskoSVPSell60,000$8.45$507,000.00View SEC Filing  
9/9/2014Gregory T BatesSVPSell5,612$5.26$29,519.12View SEC Filing  
6/3/2014John Gordon FreundDirectorBuy12,500$3.93$49,125.00View SEC Filing  
5/27/2014Cathy FriedmanDirectorBuy2,600$3.92$10,192.00View SEC Filing  
5/23/2014John Gordon FreundDirectorBuy15,000$3.73$55,950.00View SEC Filing  
5/23/2014Ronald W BarrettCEOBuy2,600$3.75$9,750.00View SEC Filing  
5/15/2014Paul BernsDirectorSell2,500$3.66$9,150.005,000View SEC Filing  
4/24/2014Paul BernsDirectorSell2,500$4.30$10,750.002,500View SEC Filing  
6/14/2013Gregory T BatesSVPSell7,500$5.35$40,125.00View SEC Filing  
5/22/2013Ernest MarioDirectorBuy20,000$5.49$109,800.00View SEC Filing  
8/9/2012Ernest MarioDirectorBuy10,000$8.50$85,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

XenoPort (NASDAQ XNPT) News Headlines

Source:
DateHeadline
Critical Comparison: Akorn (AKRX) & XenoPort (XNPT)Critical Comparison: Akorn (AKRX) & XenoPort (XNPT)
www.americanbankingnews.com - January 20 at 5:16 PM
Reviewing XenoPort (XNPT) and Its PeersReviewing XenoPort (XNPT) and Its Peers
www.americanbankingnews.com - January 19 at 5:32 PM
Head-To-Head Review: XenoPort (XNPT) vs. Its RivalsHead-To-Head Review: XenoPort (XNPT) vs. Its Rivals
www.americanbankingnews.com - January 3 at 3:36 PM
Critical Analysis: XenoPort (XNPT) vs. Its PeersCritical Analysis: XenoPort (XNPT) vs. Its Peers
www.americanbankingnews.com - January 2 at 3:16 PM
Financial Comparison: XenoPort (XNPT) versus Its CompetitorsFinancial Comparison: XenoPort (XNPT) versus Its Competitors
www.americanbankingnews.com - January 1 at 1:22 PM
Contrasting Teva Pharmaceutical Industries (TEVA) & XenoPort (XNPT)Contrasting Teva Pharmaceutical Industries (TEVA) & XenoPort (XNPT)
www.americanbankingnews.com - December 31 at 3:28 AM
Financial Review: XenoPort (XNPT) vs. Its RivalsFinancial Review: XenoPort (XNPT) vs. Its Rivals
www.americanbankingnews.com - December 24 at 5:34 PM
XenoPort (XNPT) & Its Peers Critical ReviewXenoPort (XNPT) & Its Peers Critical Review
www.americanbankingnews.com - December 23 at 7:34 AM
Head to Head Survey: XenoPort (XNPT) vs. Lannett Co (LCI)Head to Head Survey: XenoPort (XNPT) vs. Lannett Co (LCI)
www.americanbankingnews.com - November 22 at 5:24 PM
Critical Analysis: CoLucid Pharmaceuticals (CLCD) and XenoPort (XNPT)Critical Analysis: CoLucid Pharmaceuticals (CLCD) and XenoPort (XNPT)
www.americanbankingnews.com - October 9 at 8:10 AM
Arbor Pharma Announces Results of XenoPort (XNPT) Tender Offer - StreetInsider.comArbor Pharma Announces Results of XenoPort (XNPT) Tender Offer - StreetInsider.com
www.streetinsider.com - July 5 at 7:58 PM
XENOPORT INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure tXENOPORT INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure t
biz.yahoo.com - July 5 at 4:54 PM
XenoPort (XNPT) Enters MOU Over Pending Merger; Agrees to Make Additional DisclosuresXenoPort (XNPT) Enters MOU Over Pending Merger; Agrees to Make Additional Disclosures
www.streetinsider.com - June 28 at 8:20 PM
What Brexit Vote Could Mean for U.S. 2016 ElectionWhat Brexit Vote Could Mean for U.S. 2016 Election
www.marketwatch.com - June 22 at 6:52 PM
Arbor Pharmaceuticals, LLC -- Moodys Assigns B1 CFR to Arbor Pharmaceuticals; Stable OutlookArbor Pharmaceuticals, LLC -- Moody's Assigns B1 CFR to Arbor Pharmaceuticals; Stable Outlook
www.moodys.com - June 21 at 12:08 PM
Why Xenoport, Inc. Stock Jumped 61.1% in MayWhy Xenoport, Inc. Stock Jumped 61.1% in May
www.fool.com - June 4 at 9:04 AM
Arbor Pharma to Acquire XenoPort (XNPT) for $7.03/Share; Deal Valued at ~$467MArbor Pharma to Acquire XenoPort (XNPT) for $7.03/Share; Deal Valued at ~$467M
www.streetinsider.com - May 25 at 11:44 AM
Arbor Pharmaceuticals to buy XenoPort for $467MArbor Pharmaceuticals to buy XenoPort for $467M
www.bizjournals.com - May 25 at 11:44 AM
XenoPort Inc (XNPT) Stock Skyrockets on Arbor Merger AgreementXenoPort Inc (XNPT) Stock Skyrockets on Arbor Merger Agreement
www.bidnessetc.com - May 25 at 11:44 AM

SEC Filings

XenoPort (NASDAQ:XNPT) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

XenoPort (NASDAQ:XNPT) Income Statement, Balance Sheet and Cash Flow Statement

Chart

XenoPort (NASDAQ XNPT) Stock Chart for Wednesday, February, 21, 2018

Loading chart…

This page was last updated on 2/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.